Immunoassays

SLA/LP is a solid phase enzyme immunoassay employing human recombinant SLA/LP for the quantitative detection of IgG antibodies against soluble liver antigen (SLA) in human serum. The assay is a tool for the diagnosis of autoimmune hepatitis (AIH).

AMA-M2-G is a solid phase enzyme immunoassay employing native mitochondial M2 antigen for the quantitative detection of IgG antibodies against M2 in human serum. The assay is a tool in the diagnosis of the primary biliary cirrhosis (PBC).

Borrelia-G is a solid phase enzyme immunoassay for the quantitative detection of IgG antibodies against Borrelia burgdorferi. The assay is a tool in the diagnosis of Lyme borreliosis.

Borrelia-M is a solid phase enzyme immunoassay for the quantitative detection of IgM antibodies against Borrelia burgdorferi. The assay is a tool in the diagnosis of Lyme borreliosis.

Protein C is a solid phase enzyme immunoassay for the quantitative determination of Protein C in citrated human plasma. The determination of Protein C aids in the risk estimation of thrombosis.

Protein S is a solid phase enzyme immunoassay for the quantitative determination of Total and Free Protein S in citrated human plasma. The determination of Total and Free Protein S aids in the risk estimation of thrombosis.

This protocol details the procedure for testing samples with the OLM Aspergillus LFD (AspLFD). The following protocol is summarised in the figure overleaf. Please see the AspLFD handbook for more detailed product information.